NEW YORK, Aug. 1 - InforMax on Wednesday reported a slight improvement in second-quarter losses on top of a nearly 130 percent surge in revenues over the same period last year.

The Bethesda, Md.-based bioinformatics company reported a $0.17 diluted net loss per share, beating by 42 cents its earnings per share over the same period last year and by 1 penny a consensus of analysts polled by Thomson Financial/First Call.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.